Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06245057 · ClinicalTrials.gov registry record · NA
Enriched Holistic Care to Eradicate Disparities in Maternal Morbidity
A NA study of Morbidity;Perinatal, sponsored by University of Pennsylvania.
- Recruiting
- Registry status
- NA
- Development phase
- 2,300
- Enrollment target
- 2
- Study locations
NCT06245057: Recruiting NA study of Morbidity;Perinatal, sponsored by University of Pennsylvania.
NCT06245057 is a NA study of Morbidity;Perinatal that is actively recruiting participants, run by University of Pennsylvania. The registered enrollment target is 2,300 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (64% higher). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06245057, a NA study of Morbidity;Perinatal, is actively recruiting participants, sponsored by University of Pennsylvania.
- RECRUITING
- Registry status
- NA
- Development phase
- 2,300 participants
- Enrollment target
- 2
- Study locations
Study Summary
The goal of this randomized controlled intervention trial is to evaluate an integrated, interdisciplinary, multi-level maternity care home model (MCHM) aimed at reducing severe maternal morbidity (SMM) among a group of Black indigenous and people of color (BIPOC) patients. The main question it aims to answer is whether a patient-centered MCHM will address the gap in social, structural, and health system factors that contribute to disparities for the most vulnerable patients, thereby reducing SMM. Participants will be randomized to a MCHM (office-based prenatal care that is integrated with social services within the MCHM) or standard of care (office-based prenatal care with individually outsourced social services referrals) and followed during pregnancy through 1 year postpartum.
Primary Outcome
The CDC definition of SMM. We will also include postpartum hemorrhage, infection, thrombosis, readmission and maternal mortality within this definition
Conditions Studied
Interventions
- OTHER Maternity care home model (MCHM)
Study Locations (2)
Pennsylvania
- Hospital of the University of Pennsylvania - Phialdelphia
- Pennsylvania Hospital - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,300 participants |
| Start Date | 2024-01-30 |
| Est. Completion | 2028-01-31 |
| Phase | NA |
What NCT06245057 shows while recruiting
NCT06245057 is an interventional study that assigns participants to a tested intervention. Its 2,300 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (64% higher).
The record links to 1 condition, with Morbidity;Perinatal appearing as the primary indexed condition, and to 1 intervention - of which Maternity care home model (MCHM) is the first listed.
NCT06245057 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06245057 about?
NCT06245057 is a clinical study titled "Enriched Holistic Care to Eradicate Disparities in Maternal Morbidity". The goal of this randomized controlled intervention trial is to evaluate an integrated, interdisciplinary, multi-level maternity care home model (MCHM) aimed at reducing severe maternal morbidity (SMM) among a group of Black indigenous and people of color (BIPOC) patients. The main question it aims...
What is the current status of trial NCT06245057?
This trial is currently recruiting. It is a NA study. The enrollment target is 2,300 participants. The study started on 2024-01-30. Estimated completion is 2028-01-31.
What conditions does trial NCT06245057 study?
This clinical trial studies the following conditions: Morbidity;Perinatal.
What interventions are being tested in trial NCT06245057?
The interventions under investigation include: Maternity care home model (MCHM) (OTHER).
Who is sponsoring clinical trial NCT06245057?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06245057 being conducted?
This trial has 2 study locations across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Morbidity;Perinatal
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06245057's enrollment target sits among peer trials
2,300 46th of 2000 higher than 1,954 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04124120 · 2,300 participants · NA
Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women
- NCT05237258 · 2,300 participants · NA
Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia
- NCT05732623 · 2,300 participants
Exogenous and Endogenous Risk Factors for Early-onset Colorectal Cancer
- NCT05759988 · 2,300 participants · NA
Cervical Ripening as an Outpatient Method Using the Foley (COMFORT)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI